𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interest of the new criteria for drug trials in AD

✍ Scribed by B. Dubois

Book ID
107669810
Publisher
Springer
Year
2009
Tongue
English
Weight
42 KB
Volume
13
Category
Article
ISSN
1279-7707

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

French recommendations for clinical drug
French recommendations for clinical drug trials in cognitive disorders of the elderly
✍ Dr. Bernard Michel; Roland Sambuc; Jean-Claude Scotto πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 449 KB πŸ‘ 2 views

## Abstract A consensus conference on the topic of clinical drug trials in cognitive disorders of the elderly was held in Marseille on January 28–29, 1993. At the end of this conference, several recommendations were made. Drugs used in trials must be chosen according to solid neurobiological eviden

Clinical trials with the cholinergic dru
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)
✍ Albert Wettstein; RenΓ© Spiegel πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e

The American College of Rheumatology res
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity
✍ American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosu πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 3 views

## Abstract ## Objective Improved standards for the evaluation of therapeutic interventions in systemic lupus erythematosus (SLE) are needed. The purpose of this study by a committee of the American College of Rheumatology was to define clinically meaningful improvement, no change, or worsening in